Funded Tech Companies

Zentalis Pharmaceuticals

Zentalis Pharmaceuticals is a biopharmaceutical growth company, based in New York. Venture capital investment came from Farallon Capital Management, Viking Global Investors and Matrix Capital Management.

Company Overview

Contact Information

Company Background Information

Overview

At Zentalis (Nasdaq: ZNTL), we are developing clinically differentiated therapeutics targeting fundamental cancer pathways that have the potential to address major unmet medical needs for patients with cancer. We have successfully advanced three compounds into the clinic in the Company's first five years, all internally developed using the deep chemistry capabilities of our integrated discovery engine.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/2/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Anthony Sun

        

Chief Financial Officer

Melissa Epperly

        

Chief Medical Officer

Robert Winkler

        

Chief Operating Officer

Kevin Bunker

        

Vice President

Peter Huang

        

VP - Bus. Development

Lawrence Cripe

        

VP - General Counsel

Kimberley Overs

        

VP - Operations

Orna Bornstein

        

VP - R & D

Ahmed Samatar

        

VP - Regulatory Affairs

Meena Rao

        

Company Investors

• Farallon Capital Management
• Viking Global Investors
• Matrix Capital Management (Karan Takhar)
• Perceptive Advisors
• Redmile Group
• Eventide Asset Management
• Surveyor Capital

Browse more funded tech companies:

Zentail | Zentera

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary